<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03722095</url>
  </required_header>
  <id_info>
    <org_study_id>EC/2018/0866</org_study_id>
    <nct_id>NCT03722095</nct_id>
  </id_info>
  <brief_title>Research on the Effects of Combined Neurostimulation Protocols on Stress</brief_title>
  <official_title>The Effects of Preconditioning Theta Burst Stimulation With Transcranial Direct Current Stimulation on Stress Regulation in Healthy Controls: a Double-blind Sham-controlled Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Ghent</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>University Hospital, Ghent</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University Ghent</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The study examines the effects of the combined use of two different non-invasive brain
      stimulation (NIBS) techniques targeting the DLPFC on stress reactivity and recovery.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Transcranial Direct Current Stimulation (tDCS) will be combined with intermittent Theta Burst
      Stimulation (iTBS) in order to maximize the effects coming from each of the techniques on
      their own. A group of 74 healthy participants wil be submitted to two different stimulation
      protocols (sham tDCS + active iTBS and active tDCS + active iTBS) with one-week in between
      and results on stress reactivity will be examined. In order to improve therapeutic protocols,
      this study with healthy participants is a crucial first step in order to further conduct
      clinical studies with psychiatric samples.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">October 29, 2018</start_date>
  <completion_date type="Anticipated">November 1, 2019</completion_date>
  <primary_completion_date type="Anticipated">November 1, 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Other</primary_purpose>
    <masking>Triple (Participant, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Changes in heart rate variability (HRV)</measure>
    <time_frame>Through study completion, an average of two weeks</time_frame>
    <description>Variability in time between two heartbeats</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Changes in heart rate (HR)</measure>
    <time_frame>Through study completion, an average of two weeks</time_frame>
    <description>Beats per minute</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Changes in blood pressure (BP)</measure>
    <time_frame>Through study completion, an average of two weeks</time_frame>
    <description>Both systolic and diastolic blood pressure (SBP/DBP)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Changes in electrodermal activity (EDA)</measure>
    <time_frame>Through study completion, an average of two weeks</time_frame>
    <description>Peak amplitudes of Skin Conductive Responses (SCRs)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Changes in state-dependent mood</measure>
    <time_frame>Through study completion, an average of two weeks</time_frame>
    <description>Visual analogue scales (VAS): total scores will be reported (range 0 to 10) with higher scores indicating worse outcome</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Changes in state-dependent ruminative thinking</measure>
    <time_frame>Through study completion, an average of two weeks</time_frame>
    <description>Brief State Rumination Inventory (BSRI): total scores will be reported (range 0 to 80) with higher scores indicating worse outcome</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Changes in anxiety features - self-report</measure>
    <time_frame>Through study completion, an average of two weeks</time_frame>
    <description>State/Trait Anxiety Inventory (STAI): total scores will be reported (range 0 to 160) with higher scores indicating worse outcome</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">74</enrollment>
  <condition>Stress Reaction</condition>
  <condition>Stress Related Disorder</condition>
  <condition>Major Depressive Disorder</condition>
  <arm_group>
    <arm_group_label>active tDCS + active iTBS</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Participants will receive 20 minutes of active tDCS, during the last 7 minutes active iTBS will be applied.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>sham tDCS + active iTBS</arm_group_label>
    <arm_group_type>Sham Comparator</arm_group_type>
    <description>Participants will receive 20 minutes of sham tDCS, during the last 7 minutes active iTBS will be applied.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>active tDCS</intervention_name>
    <description>A current of 2 milliamp√®re (mA) through electrodes of 5x5cm.</description>
    <arm_group_label>active tDCS + active iTBS</arm_group_label>
    <other_name>active/anodal transcranial direct current stimulation</other_name>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>sham tDCS</intervention_name>
    <description>Similar set-up as in the active tDCS, but stimulation is too short to cause any effects.</description>
    <arm_group_label>sham tDCS + active iTBS</arm_group_label>
    <other_name>sham transcranial direct current stimulation</other_name>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>iTBS</intervention_name>
    <description>54 cycles with 10 bursts of 3 pulses, train duration of 2 seconds and intertrain intervals of 6 seconds, results in 1620 pulses at 110% resting motor threshold.</description>
    <arm_group_label>active tDCS + active iTBS</arm_group_label>
    <arm_group_label>sham tDCS + active iTBS</arm_group_label>
    <other_name>intermittent theta burst stimulation</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

        - Aged between 18-45 years old

        Exclusion Criteria:

          -  The presence of psychiatric disorders

          -  Usage of psychotropic medication

          -  Any or cardiovascular neurological condition

          -  Personal or family history of epilepsy or other neurological disorders

          -  Unstable medical condition, as well as chronic pain conditions, (such as fibromyalgia)
             or increased blood pressure

          -  Eye disease(s)

          -  Current substance abuse

          -  Inner ear prosthesis

          -  Any implanted electronic device susceptible for magnetic field radiation (e.g.
             pacemaker)

          -  Any implanted metal device in the head region

          -  Metal objects or magnetic objects in the brain or around the head (only removable
             earrings &amp; piercing are allowed)

          -  Recent neurosurgical interventions

          -  Pregnancy

          -  Skin problems in the head region

          -  Recent fractures or wounds on the hand
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>45 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Chris Baeken, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Ghent University, University Hospital Ghent</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Marie-Anne Vanderhasselt, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Ghent University, University Hospital Ghent</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Stefaan Van Damme, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Ghent</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Chris Baeken, MD, PhD</last_name>
    <phone>+3293325543</phone>
    <email>Chris.Baeken@ugent.be</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Stefanie De Smet, M.Sc.</last_name>
    <email>Stefanie.DeSmet@UGent.be</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>University Hospital Ghent</name>
      <address>
        <city>Ghent</city>
        <zip>9000</zip>
        <country>Belgium</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Chris Baeken</last_name>
    </contact>
    <contact_backup>
      <last_name>Stefanie De Smet</last_name>
    </contact_backup>
  </location>
  <location_countries>
    <country>Belgium</country>
  </location_countries>
  <verification_date>April 2019</verification_date>
  <study_first_submitted>October 2, 2018</study_first_submitted>
  <study_first_submitted_qc>October 25, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">October 26, 2018</study_first_posted>
  <last_update_submitted>April 23, 2019</last_update_submitted>
  <last_update_submitted_qc>April 23, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">April 25, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Non-invasive Brain Stimulation</keyword>
  <keyword>intermittent Theta Burst Stimulation (iTBS)</keyword>
  <keyword>Transcranial Direct Current Stimulation (tDCS)</keyword>
  <keyword>Dorsolateral Prefrontal Cortex</keyword>
  <keyword>Stress reactivity</keyword>
  <keyword>Stress-related Disorders</keyword>
  <keyword>Major Depressive Disorder</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Disease</mesh_term>
    <mesh_term>Fractures, Stress</mesh_term>
    <mesh_term>Depressive Disorder</mesh_term>
    <mesh_term>Depression</mesh_term>
    <mesh_term>Depressive Disorder, Major</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_description>Data will be made public on the open science framework website.</ipd_description>
    <ipd_info_type>Study Protocol</ipd_info_type>
    <ipd_info_type>Statistical Analysis Plan (SAP)</ipd_info_type>
    <ipd_info_type>Informed Consent Form (ICF)</ipd_info_type>
    <ipd_info_type>Analytic Code</ipd_info_type>
    <ipd_time_frame>After study completion.</ipd_time_frame>
    <ipd_access_criteria>Open acces</ipd_access_criteria>
    <ipd_url>https://osf.io</ipd_url>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

